Wall Street Experts
ver. ZuMIgo(08/25)
Jazz Pharmaceuticals plc
Rachunek Zysków i Strat
Przychody TTM (mln): 3 993
EBIT TTM (mln): 799
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
Rok finansowy |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
21 |
45 |
65 |
68 |
128 |
174 |
272 |
586 |
872 |
1,173 |
1,325 |
1,488 |
1,619 |
1,891 |
2,162 |
2,364 |
3,094 |
3,659 |
3,834 |
4,069 |
Przychód Δ r/r |
0.0% |
inf% |
109.2% |
45.6% |
3.4% |
90.3% |
35.3% |
56.7% |
115.2% |
48.9% |
34.4% |
13.0% |
12.3% |
8.8% |
16.8% |
14.3% |
9.3% |
30.9% |
18.3% |
4.8% |
6.1% |
Marża brutto |
0.0% |
80.0% |
84.5% |
86.4% |
79.4% |
92.5% |
92.2% |
94.9% |
86.6% |
88.3% |
90.0% |
92.3% |
92.9% |
93.2% |
93.6% |
94.1% |
93.7% |
85.8% |
85.2% |
72.8% |
100.0% |
EBIT (mln) |
-25 |
-78 |
-78 |
-139 |
-170 |
16 |
58 |
128 |
198 |
340 |
196 |
508 |
592 |
529 |
615 |
532 |
765 |
170 |
512 |
659 |
717 |
EBIT Δ r/r |
0.0% |
216.3% |
-0.5% |
77.8% |
22.8% |
-109.4% |
262.8% |
121.2% |
54.8% |
72.0% |
-42.5% |
159.8% |
16.4% |
-10.6% |
16.3% |
-13.4% |
43.8% |
-77.8% |
200.8% |
28.7% |
8.7% |
EBIT (%) |
0.0% |
-365.8% |
-174.0% |
-212.5% |
-252.3% |
12.4% |
33.3% |
46.9% |
33.8% |
39.0% |
16.7% |
38.4% |
39.8% |
32.7% |
32.5% |
24.6% |
32.4% |
5.5% |
14.0% |
17.2% |
17.6% |
Koszty finansowe (mln) |
0 |
0 |
0 |
-14 |
20 |
23 |
13 |
2 |
17 |
27 |
53 |
57 |
62 |
78 |
77 |
72 |
100 |
279 |
288 |
351 |
238 |
EBITDA (mln) |
-25 |
-30 |
-98 |
-98 |
-100 |
24 |
78 |
137 |
272 |
422 |
564 |
638 |
717 |
766 |
859 |
997 |
1,025 |
696 |
1,111 |
1,298 |
717 |
EBITDA(%) |
0.0% |
-137.6% |
-219.0% |
-150.5% |
-147.7% |
18.4% |
44.8% |
50.3% |
46.4% |
48.4% |
48.1% |
48.2% |
48.2% |
47.3% |
45.4% |
46.1% |
43.4% |
22.5% |
30.4% |
33.9% |
17.6% |
Podatek (mln) |
25 |
28 |
-19 |
0 |
44 |
23 |
25 |
3 |
-84 |
92 |
94 |
106 |
135 |
-48 |
80 |
-73 |
34 |
216 |
-159 |
-120 |
-90 |
Zysk Netto (mln) |
-25 |
-85 |
-59 |
-139 |
-184 |
-7 |
33 |
125 |
289 |
216 |
58 |
330 |
397 |
488 |
447 |
523 |
239 |
-329 |
-214 |
415 |
560 |
Zysk netto Δ r/r |
0.0% |
243.3% |
-30.3% |
133.7% |
32.8% |
-96.3% |
-579.5% |
281.3% |
130.9% |
-25.0% |
-73.0% |
464.4% |
20.4% |
22.9% |
-8.4% |
17.1% |
-54.4% |
-237.9% |
-34.9% |
-293.7% |
35.0% |
Zysk netto (%) |
0.0% |
-397.1% |
-132.4% |
-212.6% |
-273.0% |
-5.3% |
18.9% |
45.9% |
49.2% |
24.8% |
5.0% |
24.9% |
26.7% |
30.1% |
23.6% |
24.2% |
10.1% |
-10.6% |
-5.9% |
10.8% |
13.8% |
EPS |
-1.84 |
-6.32 |
-4.41 |
-10.04 |
-7.19 |
-0.23 |
0.9 |
3.01 |
5.09 |
3.71 |
0.98 |
5.38 |
6.56 |
8.13 |
7.45 |
9.22 |
4.28 |
-5.51 |
-3.42 |
6.55 |
9.06 |
EPS (rozwodnione) |
-1.84 |
-6.32 |
-4.41 |
-10.04 |
-7.19 |
-0.23 |
0.83 |
2.67 |
4.79 |
3.51 |
0.93 |
5.23 |
6.41 |
7.96 |
7.3 |
9.09 |
4.22 |
-5.51 |
-3.42 |
6.1 |
8.49 |
Ilośc akcji (mln) |
13 |
13 |
13 |
14 |
26 |
30 |
36 |
41 |
57 |
58 |
60 |
61 |
60 |
60 |
60 |
57 |
56 |
60 |
63 |
63 |
62 |
Ważona ilośc akcji (mln) |
13 |
13 |
13 |
14 |
26 |
30 |
39 |
47 |
60 |
62 |
63 |
63 |
62 |
61 |
61 |
58 |
57 |
60 |
63 |
72 |
66 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |